These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28550277)

  • 1. Escherichia coli PagP Enzyme-Based De Novo Design and In Vitro Activity of Antibacterial Peptide LL-37.
    Yang H; Fu J; Zhao Y; Shi H; Hu H; Wang H
    Med Sci Monit; 2017 May; 23():2558-2564. PubMed ID: 28550277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37.
    Ciornei CD; Sigurdardóttir T; Schmidtchen A; Bodelsson M
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2845-50. PubMed ID: 15980359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli.
    Aghazadeh H; Memariani H; Ranjbar R; Pooshang Bagheri K
    Chem Biol Drug Des; 2019 Jan; 93(1):75-83. PubMed ID: 30120878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant
    Morroni G; Sante LD; Simonetti O; Brescini L; Kamysz W; Kamysz E; Mingoia M; Brenciani A; Giovanetti E; Bagnarelli P; Giacometti A; Cirioni O
    Future Microbiol; 2021 Mar; 16():221-227. PubMed ID: 33646013
    [No Abstract]   [Full Text] [Related]  

  • 5. The fabrication and in vitro properties of antibacterial polydopamine-LL-37-POPC coatings on micro-arc oxidized titanium.
    He Y; Zhang Y; Shen X; Tao B; Liu J; Yuan Z; Cai K
    Colloids Surf B Biointerfaces; 2018 Oct; 170():54-63. PubMed ID: 29874631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide Phosphorylation by the WaaY Kinase Affects the Susceptibility of Escherichia coli to the Human Antimicrobial Peptide LL-37.
    Bociek K; Ferluga S; Mardirossian M; Benincasa M; Tossi A; Gennaro R; Scocchi M
    J Biol Chem; 2015 Aug; 290(32):19933-41. PubMed ID: 26100635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RL-37, an alpha-helical antimicrobial peptide of the rhesus monkey.
    Zhao C; Nguyen T; Boo LM; Hong T; Espiritu C; Orlov D; Wang W; Waring A; Lehrer RI
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2695-702. PubMed ID: 11557457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-Terminal VPRTES Tail of LL-37 Influences the Mode of Attachment to a Lipid Bilayer and Antimicrobial Activity.
    de Miguel Catalina A; Forbrig E; Kozuch J; Nehls C; Paulowski L; Gutsmann T; Hildebrandt P; Mroginski MA
    Biochemistry; 2019 May; 58(19):2447-2462. PubMed ID: 31016971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids.
    Barańska-Rybak W; Sonesson A; Nowicki R; Schmidtchen A
    J Antimicrob Chemother; 2006 Feb; 57(2):260-5. PubMed ID: 16387752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.
    Nan YH; Bang JK; Jacob B; Park IS; Shin SY
    Peptides; 2012 Jun; 35(2):239-47. PubMed ID: 22521196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sparse Neural Network Models of Antimicrobial Peptide-Activity Relationships.
    Müller AT; Kaymaz AC; Gabernet G; Posselt G; Wessler S; Hiss JA; Schneider G
    Mol Inform; 2016 Dec; 35(11-12):606-614. PubMed ID: 27870247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects and mechanisms of the secondary structure on the antimicrobial activity and specificity of antimicrobial peptides.
    Mai XT; Huang J; Tan J; Huang Y; Chen Y
    J Pept Sci; 2015 Jul; 21(7):561-8. PubMed ID: 25826179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13.
    Bucki R; Namiot DB; Namiot Z; Savage PB; Janmey PA
    J Antimicrob Chemother; 2008 Aug; 62(2):329-35. PubMed ID: 18456648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Titanium surfaces immobilized with the major antimicrobial fragment FK-16 of human cathelicidin LL-37 are potent against multiple antibiotic-resistant bacteria.
    Mishra B; Wang G
    Biofouling; 2017 Aug; 33(7):544-555. PubMed ID: 28675109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei.
    Kanthawong S; Bolscher JG; Veerman EC; van Marle J; de Soet HJ; Nazmi K; Wongratanacheewin S; Taweechaisupapong S
    Int J Antimicrob Agents; 2012 Jan; 39(1):39-44. PubMed ID: 22005071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against
    Mori T; Yoshida M; Hazekawa M; Ishibashi D; Hatanaka Y; Nagao T; Kakehashi R; Kojima H; Uno R; Ozeki M; Kawasaki I; Yamashita T; Nishikawa J; Uchida T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular insights into the interactions of GF-17 with the gram-negative and gram-positive bacterial lipid bilayers.
    Jahangiri S; Jafari M; Arjomand M; Mehrnejad F
    J Cell Biochem; 2018 Nov; 119(11):9205-9216. PubMed ID: 30076752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of uropathogenic Escherichia coli OmpT in the resistance against human cathelicidin LL-37.
    Brannon JR; Thomassin JL; Desloges I; Gruenheid S; Le Moual H
    FEMS Microbiol Lett; 2013 Aug; 345(1):64-71. PubMed ID: 23710656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli.
    Chen X; Niyonsaba F; Ushio H; Okuda D; Nagaoka I; Ikeda S; Okumura K; Ogawa H
    J Dermatol Sci; 2005 Nov; 40(2):123-32. PubMed ID: 15963694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37.
    Wang G; Epand RF; Mishra B; Lushnikova T; Thomas VC; Bayles KW; Epand RM
    Antimicrob Agents Chemother; 2012 Feb; 56(2):845-56. PubMed ID: 22083479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.